Cargando…
Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac
OBJECTIVE: To evaluate the effectiveness of prophylactic administration of nepafenac 0.1% in maintaining mydriasis and in preventing postoperative macular edema following cataract surgery. METHODS: This was a prospective, randomized, single-masked comparative study in 60 patients undergoing phacoemu...
Autores principales: | Cervantes-Coste, Guadalupe, Sánchez-Castro, Yuriana G, Orozco-Carroll, Mónica, Mendoza-Schuster, Erick, Velasco-Barona, Cecilio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708994/ https://www.ncbi.nlm.nih.gov/pubmed/19668569 |
Ejemplares similares
-
Topical nepafenac in the treatment of diabetic macular edema
por: Callanan, David, et al.
Publicado: (2008) -
Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis, Athanassios K, et al.
Publicado: (2020) -
Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020) -
Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy
por: Sánchez-Castro, Grimelda Yuriana, et al.
Publicado: (2008) -
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
por: Hariprasad, Seenu M, et al.
Publicado: (2009)